ACARIX logo

Acarix AB (publ) Stock Price

OM:ACARIX Community·SEK 298.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author

ACARIX Share Price Performance

SEK 0
-0.24 (-100.00%)
SEK 0
-0.24 (-100.00%)
Price SEK 0

ACARIX Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

High growth potential with adequate balance sheet.

3 Risks
1 Reward

Acarix AB (publ) Key Details

SEK 8.1m

Revenue

SEK 1.3m

Cost of Revenue

SEK 6.8m

Gross Profit

SEK 49.6m

Other Expenses

-SEK 42.8m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 13, 2026
-0.036
84.42%
-530.83%
0%
View Full Analysis

About ACARIX

Founded
2009
Employees
8
CEO
Aamir Mahmood
WebsiteView website
www.acarix.com

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to support clinical decision making at the point of care. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.

Recent ACARIX News & Updates

Recent updates

No updates